Carl Dambkowski's Net Worth

$14.1 Million

Estimate Recalculated Nov 11, 2024 08:52AM EST

Who is Carl Dambkowski?

Carl Dambkowski has an estimated net worth of $14.1 Million. This is based on reported shares across multiple companies, which include Apogee Therapeutics, Inc., and Oruka Therapeutics, Inc..

SEC CIK

Carl Dambkowski's CIK is 0001983476

Past Insider Trading and Trends

2023 was Carl Dambkowski's most active year for acquiring shares with 1 total transactions. Carl Dambkowski's most active month to acquire stocks was the month of November. 2024 was Carl Dambkowski's most active year for disposing of shares, totalling 7 transactions. Carl Dambkowski's most active month to dispose stocks was the month of July. 2023 saw Carl Dambkowski paying a total of $0.00 for 175,345 shares, this is the most they've acquired in one year. In 2024 Carl Dambkowski cashed out on 19,995 shares for a total of $840,723.19, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Apogee Therapeutics, Inc. (APGE) Snapshot price: $47.25

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-2.43%
-6.67K
$59.12
-$394,041.10
267.46K
Scheduled
Nov 6
Form 4
-2.32%
-6.67K
$47.56
-$316,969.44
280.79K
Scheduled
Sep 4
Form 4
-2.49%
-7.33K
$40.67
-$298,335.79
287.46K
Scheduled
Aug 7
Form 4
-1.99%
-6.00K
$37.60
-$225,417.96
294.79K
Scheduled
Jul 3
Form 4
—
0
—
—
0
Dec 18
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Oruka Therapeutics, Inc. (ABIO) Snapshot price: $2.48

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found